Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Br J Nutr ; 131(11): 1844-1851, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38443203

ABSTRACT

The primary goal of the investigation was to analyse the anti-inflammatory and antioxidant properties of Gamma-linolenic acid (GLA) on rats with indomethacin (IND)-induced gastric ulcers. Thirty rats were divided into five groups: Control, IND (50 mg/kg, p.o.), IND pretreated with GLA 100 mg/kg (p.o. for 14 d), IND pretreated with GLA 150 mg/kg (p.o. for 14 d) and IND pretreated with omeprazole (20 mg/kg, p.o. for 14 d). The stomach tissues were examined to calculate the ulcer index and pH and analyse biochemical markers (prostaglandin E2 (PGE2), cyclooxygenase 1 (COX1), TNF-1, IL-6 and intercellular adhesion molecule-1 (ICAM1)) and oxidative stress parameters (malondialdehyde: (MDA), superoxide dismutase (SOD), glutathione (GSH) and CAT (catalase)) as well as undergo histopathological assessment. GLA 100 and 150 mg/kg showed a protective effect against IND-induced gastric damage. It reduced levels of COX1, TNF-1, IL-6 and ICAM and increased PGE2 levels. GLA also normalised antioxidant function by modulating MDA, SOD, GSH and CAT. GLA intervention protects against IND-induced gastric ulcers by restoring oxidant/antioxidant balance and reducing inflammation.


Subject(s)
Antioxidants , Dinoprostone , Indomethacin , Oxidative Stress , Rats, Wistar , Stomach Ulcer , gamma-Linolenic Acid , Animals , Stomach Ulcer/chemically induced , Stomach Ulcer/prevention & control , Stomach Ulcer/drug therapy , Indomethacin/adverse effects , Antioxidants/pharmacology , Rats , Oxidative Stress/drug effects , gamma-Linolenic Acid/pharmacology , Male , Dinoprostone/metabolism , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Gastric Mucosa/metabolism , Interleukin-6/metabolism , Intercellular Adhesion Molecule-1/metabolism , Superoxide Dismutase/metabolism , Anti-Ulcer Agents/pharmacology , Anti-Ulcer Agents/therapeutic use , Glutathione/metabolism , Tumor Necrosis Factor-alpha/metabolism , Anti-Inflammatory Agents/pharmacology , Cyclooxygenase 1/metabolism , Malondialdehyde/metabolism , Omeprazole/pharmacology
2.
J Sep Sci ; 47(11): e2400195, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38819780

ABSTRACT

This study presents a comprehensive strategy for the selection and optimization of solvent systems in countercurrent chromatography (CCC) for the effective separation of compounds. With a focus on traditional organic solvent systems, the research introduces a "sweet space" strategy that merges intuitive understanding with mathematical accuracy, addressing the significant challenges in solvent system selection, a critical bottleneck in the widespread application of CCC. By employing a combination of volume ratios and graphical representations, including both regular and trirectangular tetrahedron models, the proposed approach facilitates a more inclusive and user-friendly strategy for solvent system selection. This study demonstrates the potential of the proposed strategy through the successful separation of gamma-linolenic acid, oleic acid, and linoleic acid from borage oil, highlighting the strategy's effectiveness and practical applicability in CCC separations.


Subject(s)
Countercurrent Distribution , Plant Oils , Solvents , Solvents/chemistry , Plant Oils/chemistry , Plant Oils/isolation & purification , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/isolation & purification , gamma-Linolenic Acid
3.
Arch Microbiol ; 204(10): 635, 2022 Sep 20.
Article in English | MEDLINE | ID: mdl-36127512

ABSTRACT

γ-Linolenic acid (GLA) is an essential n-6 polyunsaturated fatty acid (PUFA) that has received considerable attention in human and animal feed. GLA is used in many nutritional and medicinal applications, such as the treatment of cancer, inflammatory disorders, and diabetes. Currently, plant seed is the primary dietary source of GLA that is not enough to utilize on an industrial scale. To generate a sustainable novel source of GLA, the gene of delta-6 desaturase, one of the essential enzymes in the GLA production pathway, was isolated from Mucor rouxii DSM1194 and expressed in P. pastoris GS115 by pPICZC vector. The recombinant yeast expressed the GLA up to 19.2% (72 mg/g) of total fatty acids. GLA production of recombinant yeast was studied in a fermenter by oil waste for 5 days, and results detected 6.3 g/l lipid, and 103 mg/g GLA was produced in 72 h. The present study may provide an opportunity to develop an alternative host for manufacturing GLA on an industrial scale.


Subject(s)
Pichia , Saccharomycetales , gamma-Linolenic Acid , Fatty Acid Desaturases/genetics , Fatty Acid Desaturases/metabolism , Fatty Acids/metabolism , Pichia/genetics , Pichia/metabolism , Saccharomycetales/genetics , Saccharomycetales/metabolism , gamma-Linolenic Acid/metabolism
4.
Endocr J ; 68(4): 421-428, 2021 Apr 28.
Article in English | MEDLINE | ID: mdl-33361692

ABSTRACT

Diabetic retinopathy (DR), one of the major complications of diabetes, can cause blindness and reduce quality of life. Dyslipidemia is reported to be associated with DR, whereas arachidonic acid may have a protective effect against DR. We aimed to investigate the association of circulating n-3 and n-6 polyunsaturated fatty acids (PUFAs) with DR. In this cross-sectional study, 190 Japanese patients with type 2 diabetes were classified as no diabetic retinopathy (NDR), simple diabetic retinopathy (SDR), or proliferative diabetic retinopathy (PDR) including pre-proliferative diabetic retinopathy. Circulating fatty acids (FAs) were measured by gas chromatograph-mass spectrometry. Logistic regression analysis was performed to investigate the association between the levels of FAs and the presence of DR. The average age, body mass index and the duration of diabetes were 62.7 ± 12.1 years, 25.0 ± 4.5 kg/m2, and 9.8 ± 8.7 years, respectively. Twenty-seven patients were diagnosed with DR. Circulating levels of dihomo-gamma-linolenic acid (DGLA) in the NDR (n = 163), SDR (n = 13) and PDR (n = 14) groups were 28.3 ± 11.0 µg/mL, 24.4 ± 9.7 µg/mL, and 21.8 ± 6.2 µg/mL, respectively (p = 0.032). The logarithm of circulating DGLA levels was associated with the presence of DR after adjusting for covariates (OR of 1-unit increment: 0.79, 95% CI: 0.62-1.00, p = 0.049). Circulating DGLA was negatively associated with the presence of DR.


Subject(s)
8,11,14-Eicosatrienoic Acid/blood , Diabetes Mellitus, Type 2/blood , Diabetic Retinopathy/blood , Aged , Body Mass Index , Cross-Sectional Studies , Fatty Acids, Nonesterified/blood , Female , Humans , Male , Middle Aged
5.
Chin J Physiol ; 64(4): 202-209, 2021.
Article in English | MEDLINE | ID: mdl-34472451

ABSTRACT

Gamma-linolenic acid (GLA), a natural fatty acid obtained from oils of various vegetables and seeds, has been demonstrated as an anticancer agent. In this work, we investigated the anticancer effects of GLA on breast cancer BT-474 cells. GLA at 30 µM, a concentration reportedly within the range of circulating concentrations in clinical studies, caused apoptotic cell death. GLA caused an elevation in mitochondrial Ca2+ level and a decrease in mitochondrial membrane potential. GLA treatment depleted cyclopiazonic acid (CPA)-sensitive Ca2+ store and triggered substantial Ca2+ influx. Intracellular Ca2+ release triggered by GLA was suppressed by 3 µM xestospongin C (XeC, IP3 receptor-channel blocker) and 100 µM ryanodine (ryanodine receptor-channel blocker), suggesting that the Ca2+ release was via IP3 receptor-channel and ryanodine receptor-channel. Increased expressions of p-eIF2α and CHOP were observed in GLA-treated cells, suggesting GLA-treated cells had increased expressions of p-eIF2α and CHOP, which suggest endoplasmic reticulum (ER) stress. In addition, GLA elicited increased production of reactive oxygen species. Taken together, our results suggest a basal level of GLA induced apoptotic cell death by causing Ca2+ overload, mitochondrial dysfunction, Ca2+ store depletion, ER stress, and oxidative stress. This is the first report to show that GLA caused Ca2+ store depletion and ER stress. GLA-induced Ca2+ store depletion resulted from opening of IP3 receptor-channel and ryanodine receptor-channel.


Subject(s)
Breast Neoplasms , gamma-Linolenic Acid , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Calcium/metabolism , Endoplasmic Reticulum/metabolism , Female , Humans , Oxidative Stress , gamma-Linolenic Acid/metabolism
6.
J Food Sci Technol ; 58(3): 844-854, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33678867

ABSTRACT

Diplazium maximum (D. Don) C. Chr. is a wild edible fern, traditionally consumed in the tribal areas of western Himalayas. The edible part of the plant (young fronds) was analyzed for its nutritional and phytochemical composition. The dried young fronds (DYF) were found to have high contents of dietary fibre (38.32 g/100 g dry basis) and crude protein (25.39 g/100 g dry basis). Branched-chain-essential-amino acids, polyunsaturated fatty acids (PUFA) (constituting more than 50% of total fatty acids), dihomo-gamma-linolenic acid (unique omega-6 PUFA) and phenolics like epicatechin, myricetin, catechin and procatechuic acid were present in nutritionally significant amounts. Hydro-alcoholic extracts of the DYF contained maximum distribution of polyphenols and flavonoids and exhibited high antioxidant capacities. Analysis of functional properties of DYF such as water and oil absorption capacity, dispersibility and swelling capacity indicated its potential application in instant convenience food products such as soup mixes. Sensory scores of soup mix prepared using DYF was similar to that of commercially available soups. In conclusion, D. maximum is nutritious enough to be popularized for domestication, wide consumption and inclusion in the form of instant food products in existing food basket.

7.
Prostaglandins Other Lipid Mediat ; 150: 106452, 2020 10.
Article in English | MEDLINE | ID: mdl-32439412

ABSTRACT

Glioblastoma multiforme (GBM) is the most malignant astrocytoma, the main treatments consist of surgical resection followed by radiotherapy and chemotherapy. Patients, after diagnosed, have a survival rate of one year. GBM cells have an invasive, proliferative and migratory characteristic, also they do not respond properly for usual cancer treatment (radiotherapy, chemotherapy). Fatty acids have been studied as an adjuvant cancer treatment in breast, colorectal and GBM. The fatty acid can alter tumoural cell metabolism causing a modification of eicosanoids production. This study has observed some cellular aspects modified by fatty acid treatment in vitro, using GBM cells (human and rat). Modifications in cell behaviour were analyzed like cell proliferation, apoptosis, migration and invasion cell capacity after treatment with fatty acid (gamma-linolenic acid). The treatment suggested in this study showed an increased number of apoptotic cells and a decreased number of proliferative and migratory cells. These data recognize that gamma-linolenic acid could be used as an alternative treatment for glioblastoma.


Subject(s)
Brain Neoplasms/drug therapy , Brain Neoplasms/pathology , Glioblastoma/drug therapy , Glioblastoma/pathology , gamma-Linolenic Acid/pharmacology , Animals , Apoptosis/drug effects , Cell Movement , Cell Proliferation/drug effects , Humans , Rats , Tumor Cells, Cultured
8.
Cell Biochem Funct ; 38(5): 591-603, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32207176

ABSTRACT

Gamma linolenic acid is a polyunsaturated fatty acid having selective anti-tumour properties with negligible systemic toxicity. In the present study, the anti-cancer potential of gamma linolenic acid and its effects on mitochondrial as well as hypoxia-associated marker was evaluated. The effect of gamma linolenic acid was scrutinised against ER + MCF-7 cells by using fluorescence microscopy, JC-1 staining, dot plot assay and cell cycle analysis. The in vitro results were also confirmed using carcinogen (n-methyl-n-nitrosourea) induced in vivo model. The early and late apoptotic signals in the conjugation with mitochondrial depolarisation were found once scrutinised through mitochondrial membrane potential and life death staining after gamma linolenic acid treatment. Gamma linolenic acid arrested the cell cycle in G0/G1 phase with the majority of cell populations in the early apoptotic stage. The translocation of phosphatidylserine was studied through annexin-V FITC dot plot assay. The markers of cellular proliferation (decreased alveolar bud count, histopathological architecture restoration and loss of tumour micro-vessels) were diminished after gamma linolenic acid treatment. Gamma linolenic acid ameliorates the biological effects of n-methyl-n-nitrosourea persuading the mitochondrial mediated death pathway and impeding the hypoxic microenvironment to make a halt in palmitic acid synthesis. SIGNIFICANCE: The present study elaborates the effect of gamma linolenic acid on mammary gland cancer by following mitochondrial-mediated death apoptosis pathway. Gamma linolenic acid also inhibits cell-wall synthesis by the curtailment of HIF-1α and FASN level in mammary gland cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Breast Neoplasms/drug therapy , Fatty Acid Synthases/antagonists & inhibitors , Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors , Mitochondria/drug effects , gamma-Linolenic Acid/pharmacology , Breast Neoplasms/chemically induced , Breast Neoplasms/pathology , Cell Cycle/drug effects , Cell Proliferation/drug effects , Fatty Acid Synthases/metabolism , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , MCF-7 Cells , Membrane Potential, Mitochondrial/drug effects , Methylnitrosourea , Microscopy, Fluorescence , Mitochondria/metabolism , Tumor Cells, Cultured
9.
Mar Drugs ; 18(3)2020 Mar 04.
Article in English | MEDLINE | ID: mdl-32143330

ABSTRACT

High-fat and high-sucrose diet (HFHSD)-induced obesity leads to oxidative stress and chronic inflammatory status. However, little is known about the beneficial effects of total lipids extracted from Spirulina. Hence, in the present study, Spirulina lipids were extracted with chloroform/methanol (SLC) or ethanol (SLE) and then their effects on oxidative stress and inflammation in the mice fed a HFHSD were investigated. The results show that the major lipid classes and fatty acid profiles of SLC and SLE were almost similar, but the gamma-linolenic acid (GLA) and carotenoid contents in SLE was a little higher than that in SLC. Dietary 4% SLC or SLE for 12 weeks effectively decreased the hepatic lipid hydroperoxide levels as well as increased the activities and mRNA levels of antioxidant enzymes in the mice fed a HFHSD. In addition, supplementation with SLC and SLE also markedly decreased the levels of serum pro-inflammatory cytokines and the mRNA expression of pro-inflammatory cytokines in the liver and epididymal white adipose tissue of mice fed a HFHSD, and the effects of SLC and SLE were comparable. These findings confirm for the first time that dietary Spirulina lipids could alleviate HFHSD-induced oxidative stress and inflammation.


Subject(s)
Inflammation/prevention & control , Lipids/pharmacology , Oxidative Stress/drug effects , Spirulina/chemistry , Animals , Antioxidants/pharmacology , Carotenoids/analysis , Carotenoids/pharmacology , Chloroform , Diet, High-Fat , Dietary Supplements , Ethanol , Fatty Acids/analysis , Fatty Acids/pharmacology , Lipids/chemistry , Liver/drug effects , Liver/metabolism , Male , Methanol , Mice , Mice, Inbred C57BL , Solvents , Sucrose , gamma-Linolenic Acid/analysis , gamma-Linolenic Acid/pharmacology
10.
Phytother Res ; 34(10): 2628-2638, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32441049

ABSTRACT

BACKGROUND: Studies have shown that evening primrose oil (EPO) supplementation might be effective in improving lipid profile, however, the results are inconsistent. This study was performed to determine the direction and magnitude of the EPO effect on the lipid profile. METHODS: PubMed, Scopus, Cochrane Library, Embase and Web of Science databases and Google Scholar were searched up to September-2019. Meta-analysis was performed using the random-effects model. Lipid profile including high-density lipoprotein (HDL), total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL) was considered as the primary outcome. RESULTS: A total of 926 articles were identified through database searching, of which, six RCTs were included in the meta-analysis. There were six studies on HDL, TC, and TG and four studies on LDL. EPO supplementation had no significant effect on TC, TG, LDL, and HDL. However, in subgroup analysis, a significant reduction in TG at a dose of ≤4 g/day (weighted mean difference [WMD] = -37.28 mg/dl; 95% CI: -73.53 to -1.03, p = .044) and a significant increase in HDL in hyperlipidemic subjects (WMD = 5.468 mg/dl; 95% CI: 1.323 to 9.614, p = .010) was found. CONCLUSION: Oral intake of EPO at a dose of ≤4 g/day significantly reduces serum TG levels and significantly increases HDL levels in hyperlipidemic subjects.


Subject(s)
Linoleic Acids/chemistry , Lipid Metabolism/drug effects , Lipids/chemistry , Plant Oils/chemistry , gamma-Linolenic Acid/chemistry , Humans , Oenothera biennis , Randomized Controlled Trials as Topic
11.
Int J Mol Sci ; 21(3)2020 Jan 23.
Article in English | MEDLINE | ID: mdl-31979308

ABSTRACT

Omega-3 (ω-3) and omega-6 (ω-6) polyunsaturated fatty acids (PUFAs) are nowadays desirable components of oils with special dietary and functional properties. Their therapeutic and health-promoting effects have already been established in various chronic inflammatory and autoimmune diseases through various mechanisms, including modifications in cell membrane lipid composition, gene expression, cellular metabolism, and signal transduction. The application of ω-3 and ω-6 PUFAs in most common skin diseases has been examined in numerous studies, but their results and conclusions were mostly opposing and inconclusive. It seems that combined ω-6, gamma-linolenic acid (GLA), and ω-3 long-chain PUFAs supplementation exhibits the highest potential in diminishing inflammatory processes, which could be beneficial for the management of inflammatory skin diseases, such as atopic dermatitis, psoriasis, and acne. Due to significant population and individually-based genetic variations that impact PUFAs metabolism and associated metabolites, gene expression, and subsequent inflammatory responses, at this point, we could not recommend strict dietary and supplementation strategies for disease prevention and treatment that will be appropriate for all. Well-balanced nutrition and additional anti-inflammatory PUFA-based supplementation should be encouraged in a targeted manner for individuals in need to provide better management of skin diseases but, most importantly, to maintain and improve overall skin health.


Subject(s)
Acne Vulgaris/diet therapy , Dermatitis/diet therapy , Fatty Acids, Omega-3/therapeutic use , Fatty Acids, Omega-6/therapeutic use , Psoriasis/diet therapy , Acne Vulgaris/immunology , Acne Vulgaris/microbiology , Acne Vulgaris/prevention & control , Dermatitis/immunology , Dermatitis/metabolism , Dermatitis/prevention & control , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6/metabolism , Gene Expression Regulation/immunology , Gene Expression Regulation/physiology , Humans , Psoriasis/immunology , Psoriasis/prevention & control , Toll-Like Receptors/immunology , Toll-Like Receptors/metabolism , gamma-Linolenic Acid/therapeutic use
12.
Article in English | MEDLINE | ID: mdl-28259546

ABSTRACT

Oxygenases, including lipoxygenases and cytochrome P450s, generate an array of structurally diverse oxylipins that modulate distinct biological responses in mammals. Depending on the source of tissues and enzymes, distinct oxylipins are generated with inherent cellular function. Here, we report structurally different forms of 12-HETrE, with distinct biological function in tissues as well as their derived enzymatic source.


Subject(s)
8,11,14-Eicosatrienoic Acid/analogs & derivatives , 8,11,14-Eicosatrienoic Acid/metabolism , Animals , Blood Platelets/metabolism , Cytochrome P-450 Enzyme System/metabolism , Humans , Lipoxygenases/metabolism
13.
Lipids Health Dis ; 16(1): 95, 2017 May 19.
Article in English | MEDLINE | ID: mdl-28526097

ABSTRACT

Vegetable oils are obtained by mechanical extraction or cold pressing of various parts of plants, most often: seeds, fruits, and drupels. Chemically, these oils are compounds of the ester-linked glycerol and higher fatty acids with long aliphatic chain hydrocarbons (min. C14:0). Vegetable oils have a variety of properties, depending on their percentage of saturation. This article describes sea-buckthorn oil, which is extracted from the well characterized fruit and seeds of sea buckthorn. The plant has a large number of active ingredients the properties of which are successfully used in the cosmetic industry and in medicine. Valuable substances contained in sea-buckthorn oil play an important role in the proper functioning of the human body and give skin a beautiful and healthy appearance. A balanced composition of fatty acids give the number of vitamins or their range in this oil and explains its frequent use in cosmetic products for the care of dry, flaky or rapidly aging skin. Moreover, its unique unsaturated fatty acids, such as palmitooleic acid (omega-7) and gamma-linolenic acid (omega-6), give sea-buckthorn oil skin regeneration and repair properties. Sea-buckthorn oil also improves blood circulation, facilitates oxygenation of the skin, removes excess toxins from the body and easily penetrates through the epidermis. Because inside the skin the gamma-linolenic acid is converted to prostaglandins, sea-buckthorn oil protects against infections, prevents allergies, eliminates inflammation and inhibits the aging process. With close to 200 properties, sea-buckthorn oil is a valuable addition to health and beauty products.


Subject(s)
Hippophae/chemistry , Plant Oils/chemistry , Fatty Acids , gamma-Linolenic Acid/chemistry
14.
Lipids Health Dis ; 16(1): 150, 2017 Aug 14.
Article in English | MEDLINE | ID: mdl-28806965

ABSTRACT

BACKGROUND: Polyunsaturated fatty acids (PUFAs) have important roles in the pathogenesis of cardiovascular diseases. However, the clinical significance of omega-6 PUFAs in acute cardiovascular disease remains unknown. METHODS: We enrolled 417 consecutive patients with acute cardiovascular disease admitted to the cardiac intensive care unit at Juntendo University Hospital between April 2012 and October 2013. We investigated the association between serum PUFA levels and long-term mortality. Blood samples were collected after an overnight fast, within 24 h of admission. We excluded patients who received eicosapentaenoic acid therapy and those with malignancy, end-stage kidney disease, chronic hepatic disease, and connective tissue disease. RESULTS: Overall, 306 patients (mean age: 66.4 ± 15.0 years) were analysed. During the follow-up period of 2.4 ± 1.2 years, 50 patients (16.3%) died. The dihomo-gamma-linolenic acid (DGLA) levels, arachidonic acid (AA) levels, and DGLA/AA ratio were significantly lower in the nonsurvivor group than in the survivor group (DGLA: 23.2 ± 9.8 vs. 31.5 ± 12.0 µg/ml, AA: 151.1 ± 41.6 vs. 173.3 ± 51.6 µg/ml, and DGLA/AA: 0.16 ± 0.05 vs. 0.19 ± 0.06, all p < 0.01). Kaplan-Meier curves showed that survival rates were significantly higher in the higher DGLA, AA, and DGLA/AA groups than in their lower counterparts (DGLA and AA; p < 0.01, DGLA/AA; p = 0.01), although omega-3 PUFAs were not associated with prognosis. Furthermore, in patients with acute decompensated heart failure (ADHF), survival rates were significantly higher in the higher DGLA, AA, and DGLA/AA groups than in their lower counterparts (DGLA and AA; p < 0.01, DGLA/AA; p = 0.04). However, among patients with acute coronary syndrome, none of the PUFA levels were associated with prognosis. Among patients with ADHF, after controlling for confounding variables, DGLA and DGLA/AA were associated with long-term mortality [DGLA: hazard ratio (HR), 0.94; 95% confidence interval (CI), 0.88-0.99; p = 0.01 and DGLA/AA: HR, 0.87; 95% CI, 0.77-0.97; p < 0.01], whereas AA was not associated with prognosis. CONCLUSION: Low omega-6 PUFA levels, particularly DGLA, and a low DGLA/AA ratio predict long-term mortality in patients with acute cardiovascular disease and ADHF. TRIAL REGISTRATION: UMIN-CTR; UMIN000007555 .


Subject(s)
8,11,14-Eicosatrienoic Acid/blood , Acute Coronary Syndrome/blood , Acute Coronary Syndrome/diagnosis , Heart Failure/blood , Heart Failure/diagnosis , Acute Coronary Syndrome/mortality , Acute Coronary Syndrome/physiopathology , Aged , Aged, 80 and over , Analysis of Variance , Arachidonic Acid/blood , Fatty Acids, Omega-3/blood , Fatty Acids, Omega-6/blood , Female , Heart Failure/mortality , Heart Failure/physiopathology , Humans , Male , Middle Aged , Prognosis , Prospective Studies , Risk Factors , Survival Analysis
15.
Biochim Biophys Acta ; 1851(9): 1271-82, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26092623

ABSTRACT

Previous studies have demonstrated that gamma-linolenic acid (GLA) is effective against glioma cells under both in vitro and in vivo conditions. In the present study we determined how GLA alone or in combination with irradiation alters the fatty acid (FA) and lipid profiles, the lipid droplet (LD) content, the lipid biosynthetic gene expression and the apoptosis of glioma cells. In GLA-treated cells direct correlations were found between the levels of various FAs and the expression of the corresponding FA biosynthetic genes. The total levels of saturated and monosaturated FAs decreased in concert with the down-regulation of FASN and SCD1 gene expression. Similarly, decreased FADS1 gene expression was paralleled by lowered arachidonic acid (20:4 n-6) and eicosapentaenoic acid (20:5 n-3) contents, while the down-regulation of FADS2 expression was accompanied by a diminished docosahexaenoic acid (22:6 n-3) content. Detailed mass spectrometric analyses revealed that individual treatments gave rise to distinct lipidomic fingerprints. Following uptake, GLA was subjected to elongation, resulting in dihomo-gamma-linolenic acid (20:3 n-6, DGLA), which was used for the synthesis of the LD constituent triacylglycerols and cholesteryl esters. Accordingly, an increased number of LDs were observed in response to GLA administration after irradiation. GLA increased the radioresponsiveness of U87 MG cells, as demonstrated by an increase in the number of apoptotic cells determined by FACS analysis. In conclusion, treatment with GLA increased the apoptosis of irradiated glioma cells, and GLA might therefore increase the therapeutic efficacy of irradiation in the treatment of gliomas.


Subject(s)
Gene Expression Regulation, Neoplastic , Lipid Droplets/drug effects , Lipid Metabolism/drug effects , Neuroglia/drug effects , Radiation-Sensitizing Agents/pharmacology , gamma-Linolenic Acid/pharmacology , 8,11,14-Eicosatrienoic Acid/metabolism , Apoptosis/drug effects , Apoptosis/radiation effects , Arachidonic Acid/metabolism , Cell Line, Tumor , Cholesterol Esters/metabolism , Delta-5 Fatty Acid Desaturase , Docosahexaenoic Acids/metabolism , Eicosapentaenoic Acid/metabolism , Fatty Acid Desaturases/genetics , Fatty Acid Desaturases/metabolism , Fatty Acid Synthase, Type I/genetics , Fatty Acid Synthase, Type I/metabolism , Gamma Rays , Humans , Lipid Droplets/chemistry , Lipid Droplets/metabolism , Lipid Droplets/radiation effects , Lipid Metabolism/radiation effects , Neuroglia/metabolism , Neuroglia/pathology , Neuroglia/radiation effects , Radiation-Sensitizing Agents/metabolism , Stearoyl-CoA Desaturase/genetics , Stearoyl-CoA Desaturase/metabolism , Triglycerides/metabolism , gamma-Linolenic Acid/metabolism
16.
J Anim Physiol Anim Nutr (Berl) ; 98(5): 860-6, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24251917

ABSTRACT

Plant extracts and fungal fermented feed with gamma-linolenic acid-rich microbial oils are perspective additives for use in animal nutrition as appetite and digestion stimulants, stimulants of physiological functions, for the prevention and treatment for certain pathological conditions, and as antioxidants. The activity of antioxidant enzymes and the level of reduced glutathione were measured in the plasma and in liver, heart and kidney mitochondria after 42 days of feeding broiler chickens both regular and combination diets. These were selected based on our previous experience. The administration of agrimony and gamma-linolenic acid resulted in a significant decrease in superoxide dismutase activity in all four bodies in contrast to plant extracts. We conclude that the decrease in activity is due to decreased production, and hence dismutation, of superoxide radicals to peroxides followed by lower activity of glutathione peroxidase, which was not seen in the case of only plant extract administration. Generally, higher glutathione reductase activity would be in response to increased demands on reduced glutathione as a cofactor for the reaction catalysed by glutathione peroxidase and the utilization of glutathione itself. However, measured levels of reduced glutathione showed no change. The results argue against any oxidative stress conditions. The application of agrimony extract appears to be suitable for the antioxidant effect against peroxidation of gamma-linolenic acid. As the efficacy of measuring the effects of diets on the oxidative stability of meat caused by selected antioxidant enzymes is rather low, additional data from the experiment will be processed to clearly assess the influence of this combination of diets.


Subject(s)
Antioxidants/metabolism , Chickens/metabolism , Plant Extracts/pharmacology , gamma-Linolenic Acid/pharmacology , Agrimonia , Animal Feed/analysis , Animal Nutritional Physiological Phenomena , Animals , Body Weight , Diet/veterinary , Eating , Fermentation , Fungi/metabolism , Vitis , gamma-Linolenic Acid/chemistry
17.
Ann Med Surg (Lond) ; 86(5): 2677-2683, 2024 May.
Article in English | MEDLINE | ID: mdl-38694379

ABSTRACT

Background: Gamma-linolenic acid (GLA) is found in animals and plants that play a role in brain function and metabolism. Objective: This study aimed to investigate the analgesic effects of GLA on peripheral formalin injection. Methods: Wistar rats were randomly assigned to four groups: Sham, formalin, formalin/GLA 100 mg/kg, and formalin/GLA 150 mg/kg. The Formalin test was utilized to create a pain model. A tissue sample was prepared from the spinal cords of rats to measure oxidative stress parameters and pro-inflammatory cytokines. Furthermore, the authors analyzed the expression of c-Fos protein in the spinal cords. Results: Our findings demonstrate that GLA has a reliable pain-relieving effect in the formalin test. GLA 100 increased superoxide dismutase (SOD) (P<0.05), glutathione (GSH) (P<0.001), and catalase (CAT) (P<0.05), and decreased the levels of c-Fos (P<0.001), interleukin-1 beta (IL-1ß) (P<0.001), tumour necrosis factor-alpha (TNF-α) (P<0.001), and malondialdehyde (MDA) (P<0.001) in the spinal cord. Also GLA 150 increased SOD (P<0.05), GSH (P<0.001), and CAT (P<0.05) and decreased the levels of c-Fos (P<0.001), IL-1ß (P<0.001), TNF-α (P<0.001), and MDA (P<0.001) in the spinal cord. Conclusion: The findings have validated the antinociceptive impact of GLA and hinted towards its immunomodulatory influence in the formalin test.

18.
An Bras Dermatol ; 99(2): 189-195, 2024.
Article in English | MEDLINE | ID: mdl-38061964

ABSTRACT

BACKGROUND: The development of rosacea is suggested to be closely associated with lipid metabolism, inflammation, and anxiety/depression. Gamma linolenic acid (GLA) is a key factor participating in lipid metabolism, which is also confirmed to regulate the inflammatory response. However, the associations of serum GLA levels with rosacea severity and psychological status still remain unclear. OBJECTIVE AND LIMITATIONS OF THE STUDY: The present study aimed to investigate the associations of gamma linolenic acid (GLA), a key factor participating in lipid metabolism and the inflammatory response, with rosacea severity and psychological status. The present study still had some limitations. First, this study is a cross-sectional study and does not provide longitudinal evidence about the relationship between GLA and rosacea; Second, the cohort in this study is also relatively small, and a larger cohort is needed in further investigation to reveal the potential role of lipid metabolism in the pathogenesis of rosacea. METHODS: A total of 62 rosacea patients were consecutively recruited. Patient's Self-Assessment (PSA) scale and Clinician Erythema Assessment (CEA) as well as 7-item Generalized Anxiety Disorder (GAD-7) and 9-item Patient Health Questionnaire (PHQ-9) were conducted to evaluate the degree of erythema severity and anxiety/depression, respectively. Serum GLA levels were determined by gas chromatography mass. RESULTS: Lower levels of serum GLA in rosacea patients were observed (p<0.001), and subgroup analysis revealed that patients with higher-level GLA had lower scores of PSA, CEA, GAD-7 and PHQ-9. Moreover, Spearman correlation analysis uncovered that serum GLA levels were negatively associated with PSA, CEA, GAD-7 as well and PHQ-9 scores, respectively. Linear regression model found that serum GLA levels at baseline were a predictive factor for prognosis of clinical outcomes after 1-month conventional treatment. CONCLUSION: The present study indicates that lower levels of serum GLA in rosacea patients are negatively associated with the degree of erythema and anxiety/depression status.


Subject(s)
Rosacea , gamma-Linolenic Acid , Humans , gamma-Linolenic Acid/therapeutic use , Depression/etiology , Cross-Sectional Studies , Severity of Illness Index , Rosacea/complications , Rosacea/psychology , Erythema/etiology , Erythema/drug therapy , Anxiety/etiology
19.
BMC Complement Med Ther ; 24(1): 89, 2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38360611

ABSTRACT

BACKGROUND: Evening primrose oil (EPO), extracted from the seeds of Oenothera biennis, has gained attention for its therapeutic effects in various inflammatory conditions. METHOD: We performed a systematic search in multiple databases and defined the inclusion criteria based on the following PICOs: P: Patients with a form of inflammatory condition, I: EPO, C: Placebo or other therapeutic interventions, O: changes in inflammatory markers or patients' symptoms; S: randomized controlled trials. The quality of the RCTs was evaluated using Cochrane's RoB tool. RESULTS: Several conditions were investigated in the literature. In rheumatoid arthritis, mixed results were observed, with some studies reporting significant improvements in symptoms while others found no significant impact. EPO showed some results in diabetes mellitus, atopic eczema, menopausal hot flashes, and mastalgia. However, it did not demonstrate effectiveness in chronic hand dermatitis, tardive dyskinesia, psoriatic arthritis, cystic fibrosis, hepatitis B, premenstrual syndrome, contact lens-associated dry eyes, acne vulgaris, breast cyst, pre-eclampsia, psoriasis, or primary Sjogren's syndrome. Some results were reported from multiple sclerosis after EPO consumption. Studies in healthy volunteers indicated no significant effect of EPO on epidermal atrophy, nevertheless, positive effects on the skin regarding hydration and barrier function were achieved. CONCLUSION: Some evidence regarding the potential benefits of EPO in inflammatory disorders were reported however caution is due to the limitations of the current survey. Overall, contemporary literature is highly heterogeneous and fails to provide strong recommendations regarding the efficacy of EPO on inflammatory disorders. Further high-quality studies are necessitated to draw more definite conclusions and establish O. biennis oil effectiveness as an assuring treatment option in alleviating inflammatory conditions.


Subject(s)
Oenothera biennis , Plant Oils , Humans , Plant Oils/pharmacology , Plant Oils/therapeutic use , gamma-Linolenic Acid/therapeutic use , gamma-Linolenic Acid/pharmacology , Inflammation/drug therapy , Randomized Controlled Trials as Topic , Linoleic Acids/pharmacology , Linoleic Acids/therapeutic use
20.
J Fungi (Basel) ; 10(2)2024 Feb 04.
Article in English | MEDLINE | ID: mdl-38392802

ABSTRACT

Cunninghamella elegans NRRL-1393 is an oleaginous fungus able to synthesize and accumulate unsaturated fatty acids, amongst which the bioactive gamma-linolenic acid (GLA) has potential anti-cancer activities. C. elegans was cultured in shake-flask nitrogen-limited media with either glycerol or glucose (both at ≈60 g/L) employed as the sole substrate. The assimilation rate of both substrates was similar, as the total biomass production reached 13.0-13.5 g/L, c. 350 h after inoculation (for both instances, c. 27-29 g/L of substrate were consumed). Lipid production was slightly higher on glycerol-based media, compared to the growth on glucose (≈8.4 g/L vs. ≈7.0 g/L). Lipids from C. elegans grown on glycerol, containing c. 9.5% w/w of GLA, were transformed into fatty acid lithium salts (FALS), and their effects were assessed on both human normal and cancerous cell lines. The FALS exhibited cytotoxic effects within a 48 h interval with an IC50 of about 60 µg/mL. Additionally, a suppression of migration was shown, as a significant elevation of oxidative stress levels, and the induction of cell death. Elementary differences between normal and cancer cells were not shown, indicating a generic mode of action; however, oxidative stress level augmentation may increase susceptibility to anticancer drugs, improving chemotherapy effectiveness.

SELECTION OF CITATIONS
SEARCH DETAIL